OS Therapies (OSTX) vs ProMIS Neurosciences (PMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OS Therapies (OSTX) has outperformed ProMIS Neurosciences (PMN) over the past year, losing 20.6% versus a loss of 32.4%. ProMIS Neurosciences is the larger company by market cap ($82.1 million vs $75.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OSTX | PMN |
|---|---|---|
| Share price | $1.62 | $9.15 |
| Market cap | $75.82M | $82.05M |
| 1-day change | +4.52% | +0.33% |
| YTD return | +15.71% | +33.53% |
| 1-year return | -20.59% | -32.44% |
| 5-year return | — | -95.95% |
| Forward P/E | 4.67 | — |
| EPS (TTM) | $-1.08 | $-11.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $27.40 |
| 52-week low | $1.15 | $6.27 |
| Distance from 52-week high | -28.00% | -66.61% |
| Average volume | 597.09K | 84.01K |
| Shares outstanding | 46.81M | 8.97M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OSTX has outperformed PMN by 11.9 percentage points over the past year.
OSTX vs PMN FAQ
Which is bigger, OS Therapies or ProMIS Neurosciences?
ProMIS Neurosciences (PMN) is larger, with a market capitalization of $82.05M compared with $75.82M for OS Therapies (OSTX).
Which stock has performed better over the past year, OSTX or PMN?
OSTX returned -20.59% over the past 12 months, compared with -32.44% for PMN (price return, excluding dividends). Past performance does not predict future results.
Are OS Therapies and ProMIS Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.